Home Cancer Types Cervical Cancer
Cervical Cancer
Cervical Cancer News & Features
The MAPS: Motivation and Problem Solving smoking cessation program was evaluated over 12 months, with a follow-up evaluation at 18 months, in women with cervical cancer.
A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.
Larger proportion of women with private or Medicare insurance receive diagnosis of early-stage cervical cancer.
Cervical cancer incidence has declined in recent years but have been increasing for ADC subtype at varying rates in racial and ethnic groups of women.
Compared with women aged <65 years, those aged ≥65 have lower late-stage five-year relative survival.
Load More
Cervical Cancer Clinical Trials Clinical trial focusing on Ixabepilone and cervical cancer. Ixabepilone to Treat Cervical Cancer
Clinical trial focusing on MRI guided brachytherapy. An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer (EMBRACE)
Clinical trial focusing on mapatumumab, cisplatin, and radiotherapy. Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer
Clinical trial focusing on predictive assays. Predictive Assays In Cervix Cancer
Clinical trial focusing on cervical cancer screening. Cervical Cancer Screening Among Hispanic Women
Load More
Open
Next post in Cervical Cancer
Close
Close more info about Smoking Cessation Intervention for Cervical Cancer Survivors Effective at 12 Months, Less So at 18 Months
Loading...
Close more info about Smoking Cessation Intervention for Cervical Cancer Survivors Effective at 12 Months, Less So at 18 Months
Loading...
